MyFinsight
Home
About
Contact
ptgx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, PTGX has $701,688K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
701,688
718,006
Total stockholders' equity
645,437
668,018
Total liabilities and stockholders' equity
701,688
718,006
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$9,724K
Receivable from
collaboration partner
$583K
Marketable securities
$462,404K
Cash and cash
equivalents
$113,713K
Operating lease
right-of-use asset
$8,174K
Restricted cash -
noncurrent
$287K
Property and equipment,
net
$4,100K
Marketable securities -
noncurrent
$102,703K
Total current assets
$586,424K
Total assets
$701,688K
Total liabilities and
stockholders' equity
$701,688K
Total stockholders'
equity
$645,437K
Total liabilities
$56,251K
Accumulated deficit
-$426,287K
Accumulated other
comprehensive income (loss)
$525K
Additional paid-in capital
$1,071,198K
Operating lease liability
- noncurrent
$8,521K
Deferred revenue -
noncurrent
$2,788K
Total current
liabilities
$44,942K
Common stock, 0.00001
par value,...
$1K
Operating lease liability
$2,228K
Deferred revenue
$14,200K
Accrued expenses and
other payables
$22,868K
Accounts payable
$5,646K
Subscribe for Financial Insights
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc (PTGX)